GAROFALO HEALTH CARE S.P.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.74 EUR | +0.42% |
|
+0.42% | +2.16% |
| 03-14 | GHC, revenues up but profit falls after Aurelia acquisition | AN |
| 03-14 | Garofalo Health Care S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2023 | 369M 394M 31.57B | Sales 2024 * | 463M 495M 39.64B | Capitalization | 420M 449M 35.95B |
|---|---|---|---|---|---|
| Net income 2023 | 20M 21.38M 1.71B | Net income 2024 * | 25M 26.73M 2.14B | EV / Sales 2023 | 1.67 x |
| Net Debt 2023 | 206M 220M 17.62B | Net Debt 2024 * | 179M 191M 15.33B | EV / Sales 2024 * | 1.29 x |
| P/E ratio 2023 |
25.8
x | P/E ratio 2024 * |
16.5
x | Employees | 1,907 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 32.29% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | +0.42% | ||
| 1 week | +0.42% | ||
| Current month | -3.66% | ||
| 1 month | -3.85% | ||
| 3 months | -0.21% | ||
| 6 months | +6.76% | ||
| Current year | +2.16% |
1 week
4.70
4.87
1 month
4.705.20
Current year
4.375.20
1 year
3.685.20
3 years
3.586.10
5 years
3.586.32
10 years
3.506.32
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | 61 | 19/04/00 | |
Luigi Celentano
DFI | Director of Finance/CFO | - | 30/04/21 |
| Chief Administrative Officer | - | 31/10/21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 56 | 07/08/18 | |
| Director/Board Member | 52 | - | |
| Director/Board Member | 55 | 28/04/20 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 4.74 | +0.42% | 5,344 |
| 25/04/24 | 4.72 | 0.00% | 5,736 |
| 24/04/24 | 4.72 | -1.05% | 14,411 |
| 23/04/24 | 4.77 | +0.63% | 22,674 |
| 22/04/24 | 4.74 | +0.42% | 8,051 |
Real-time Borsa Italiana, April 26, 2024 at 04:44 pm
More quotes
Garofalo Health Care SpA is an Italy-based healthcare group. The Group manages facilities across northern and central Italy, both private and accredited, providing a wide range of services and specializations covering all sectors of the health and social care sectors, among others, medicine, surgery, cardiology, rehabilitation, extended and intensive care units, psychiatric and diagnostic centers. Additionally, the Company is active in the research field in collaboration with Italian and foreign research institutions and universities.
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.74
EUR
Average target price
6.3
EUR
Spread / Average Target
+32.91%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +2.16% | 448M | |
| -20.16% | 16.21B | |
| +4.50% | 12.44B | |
| +3.98% | 11.58B | |
| +9.72% | 10.79B | |
| +23.61% | 8.26B | |
| -2.19% | 7.68B | |
| +20.75% | 7.2B | |
| +4.49% | 6.67B | |
| +50.89% | 4.66B |
- Stock Market
- Equities
- GHC Stock
